Persistence and switching characteristics among chronic migraine patient population: a retrospective claims analysis

被引:0
|
作者
Hepp, Z. [1 ]
Dodick, D. [2 ]
Varon, S. [1 ]
Gillard, P. [1 ]
Mathew, N. [3 ]
Chia, J. [3 ]
Hansen, R. [4 ]
Devine, E. B. [4 ]
机构
[1] Allergan Pharmaceut Inc, Global Hlth Outcomes Strategy & Res, Irvine, CA USA
[2] Mayo Clin, Neurol, Phoenix, AZ USA
[3] Allergan Pharmaceut Inc, Global Safety & Epidemiol, Irvine, CA USA
[4] Univ Washington, Pharmaceut Outcomes Res & Policy, Seattle, WA 98195 USA
来源
关键词
Migraine; Gabapentin; Amitriptyline; Topiramate; Chronic Migraine;
D O I
10.1186/1129-2377-15-S1-G8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EHMTI-0032
引用
收藏
页数:1
相关论文
共 50 条
  • [1] EHMTI-0032. Persistence and switching characteristics among chronic migraine patient population: a retrospective claims analysis
    Z Hepp
    D Dodick
    S Varon
    P Gillard
    N Mathew
    J Chia
    R Hansen
    EB Devine
    The Journal of Headache and Pain, 2014, 15
  • [2] Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
    Hepp, Zsolt
    Dodick, David W.
    Varon, Sepideh F.
    Chia, Jenny
    Matthew, Nitya
    Gillard, Patrick
    Hansen, Ryan N.
    Devine, Emily Beth
    CEPHALALGIA, 2017, 37 (05) : 470 - 485
  • [3] Real-World Persistence and Costs Among Patients With Chronic Migraine Treated With OnabotulinumtoxinA or CGRP mAbs: A Retrospective Claims Analysis Study
    Schwedt, Todd J.
    Lee, Jae
    Knievel, Kerry
    McVige, Jennifer
    Wang, Weiying
    Wu, Zheng
    Gillard, Patrick
    Shah, Darshini
    Blumenfeld, Andrew M.
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 18 - 19
  • [4] Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or CGRP mAbs: A retrospective claims analysis study
    Schwedt, T. J.
    Lee, J.
    Knievel, K.
    McVige, J. W.
    Wang, W.
    Wu, Z.
    Gillard, P.
    Shah, D.
    Blumenfeld, A. M.
    HEADACHE, 2022, 62 : 81 - 82
  • [5] Real-World Persistence and Costs Among Patients With Chronic Migraine Treated With OnabotulinumtoxinA or CGRP mAbs: A Retrospective Claims Analysis Study
    Schwedt, T.
    Lee, J.
    Knievel, K.
    McVige, J.
    Wang, W.
    Wu, Z.
    Gillard, P.
    Shah, D.
    Blumenfeld, A.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [6] Persistence and switching patterns of migraine prophylactic medications in Canada: A retrospective claims analysis comparing adherence and evaluating the economic burden of illness
    Ojo, Andrew Toye
    Zhang, Steven
    Zimskind, Dan
    Bleibdrey, Nataly
    Keshvani, Nasir
    Chalmers, Rob
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2022, 25 : 402 - 417
  • [7] PERSISTENCE AND SWITCHING PATTERNS OF MIGRAINE PROPHYLACTIC MEDICATIONS IN CANADA: A RETROSPECTIVE CLAIMS ANALYSIS COMPARING ADHERENCE AND EVALUATING THE ECONOMIC BURDEN OF ILLNESS
    Ojo, A.
    Zhang, S.
    Zimskind, D.
    Bleibdrey, N.
    Keshvani, N.
    Chalmers, R.
    VALUE IN HEALTH, 2022, 25 (12) : S455 - S455
  • [8] Treatment Patterns and Persistence Among Patients Newly Diagnosed With Migraine in South Korea: A Retrospective Analysis of Health Claims Data
    Kim, Ki Yeon
    Ko, Hwa Yeon
    Bea, Sungho
    Lee, Ho-Jin
    Shin, Ju-Young
    Chu, Min Kyung
    JOURNAL OF CLINICAL NEUROLOGY, 2024, 20 (05): : 529 - 536
  • [9] ANTIDIABETIC DRUG PERSISTENCE AND SWITCHING PATTERNS: A RETROSPECTIVE CLAIMS STUDY
    Park, T.
    Griggs, S.
    VALUE IN HEALTH, 2019, 22 : S160 - S160
  • [10] Comparison of persistence among therapies for overactive bladder: A retrospective pharmacy claims analysis
    Cisternas, M
    Noe, L
    Patel, B
    Remigio-Baker, R
    Williamson, T
    Black, L
    NEUROUROLOGY AND URODYNAMICS, 2005, 24 (5-6) : 580 - 581